← Back to Search

Behavioral Intervention

Executive Function Group Therapy for Autism Spectrum Disorder

N/A
Waitlist Available
Research Sponsored by Children's National Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intact or corrected hearing and vision.
14-18 years of age inclusive
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Awards & highlights

Study Summary

This trial is testing whether a cognitive behavioral intervention can help improve flexibility in ASD by looking at changes in learning and associated neural activation.

Who is the study for?
This trial is for adolescents aged 14-18 with Autism Spectrum Disorder who have an IQ over 80 and can communicate effectively in English. They must meet specific criteria on autism diagnostic tools and have normal or corrected hearing and vision. Those with metal implants, braces, pregnancy, significant neurological issues, or conditions affecting study participation are excluded.Check my eligibility
What is being tested?
The trial tests if executive function group therapy can improve learning flexibility in teens with ASD using brain scans (m-fMRI) to observe changes. It's a long-term study where participants are assessed three times over eight months to see how the therapy affects their brain activity and behavior.See study design
What are the potential side effects?
Since this is a behavioral intervention involving cognitive exercises rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience fatigue or discomfort from repetitive tasks or the MRI procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My hearing and vision are normal or corrected to normal.
Select...
I am between 14 and 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Executive Function Challenge Task (EFCT) Scores
Change in Neural Response During Prototype Learning Task Outcomes
Secondary outcome measures
Change in Adaptive Behavior Assessment System, Third Edition (ABAS-3) scores
Other outcome measures
Change in AIR-SDS Scores
Change in ASC - ASD Scores
Change in BDI-II Scores
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Executive function group therapyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,963 Previous Clinical Trials
2,674,677 Total Patients Enrolled
34 Trials studying Autism Spectrum Disorder
9,738 Patients Enrolled for Autism Spectrum Disorder
Children's National Research InstituteLead Sponsor
210 Previous Clinical Trials
207,693 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
292 Patients Enrolled for Autism Spectrum Disorder
Georgetown UniversityOTHER
343 Previous Clinical Trials
136,438 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
216 Patients Enrolled for Autism Spectrum Disorder

Media Library

Executive function group therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05131659 — N/A
Autism Spectrum Disorder Research Study Groups: Executive function group therapy
Autism Spectrum Disorder Clinical Trial 2023: Executive function group therapy Highlights & Side Effects. Trial Name: NCT05131659 — N/A
Executive function group therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05131659 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have chosen to participate in this research trial?

"Affirmative. The clinicaltrials.gov listing for this trial shows that it is currently recruiting subjects; initial posting was on October 20th 2021 and the entry has been updated as recently as August 26th 2022. There are 60 spots available across a single site."

Answered by AI

Does this experiment have any vacancies for participants?

"As per information found on clinicaltrials.gov, this trial is presently seeking applicants. It first appeared online on October 20th 2021 and has been kept up-to-date as of August 26th 2022."

Answered by AI

Does this research project offer participation to individuals such as myself?

"This clinical trial is seeking 60 individuals diagnosed with autism spectrum disorder (ASD) who are between 14 and 18 years old. To be eligible, patients must have a Full Scale IQ score above 80 on a standardized test administered within the last two years; if discrepancies exist in verbal/perceptual skills, then researchers will use the best available estimate of their Verbal IQ. Additionally, parental report confirming DSM-5 criteria for ASD diagnosis should be confirmed via Social Communication Questionnaire (raw score > 11) or Autism Diagnostic Observation Schedule-2 Module 4 (total score ≥7). Lastly, participants must possess intact vision and hearing as"

Answered by AI

Who else is applying?

What state do they live in?
Florida
New York
Pennsylvania
How old are they?
< 18
18 - 65
What site did they apply to?
Children's National Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~26 spots leftby Dec 2025